Works citing this work

7 works

Work: Unlocking the full potential of memory T cells in adoptive T cell therapy for hematologic malignancies

1. Alterations in 3D Chromatin Spatial Organisation in Tumourigenesis and Therapy Resistance of Glioblastoma: The Recent Advances in Understanding Molecular Mechanisms, Clinical Implications, and Therapeutic Perspectives

   ‎Anmar Ghanim Taki, Abdulkareem Shareef, Lalji Baldaniya +10

   ArticleGenomics and Chromatin DynamicsClinical Oncology20250 citations

   ABIABI:AkademIndex/openalex/2025.article.002218

2. Pharmacomicrobiomics in blood cancers: How the gut microbiome and its metabolites shape drug efficacy and toxicity

   Chou-Yi Hsu, Yasir Qasim Almajidi, Mohammad Abohassan +7

   ArticleGut microbiota and healthCritical Reviews in Oncology/Hematology20260 citations

   ABIABI:AkademIndex/openalex/2026.article.000310

3. Utilizing pH-sensitive nanoparticles in cancer radiotherapy: mechanisms and therapeutic potential

   Yodgor Kenjayev, Nigina Khalikova, Ozodbek Eshqobilov +3

   ArticleNanoplatforms for cancer theranosticsJournal of Nanoparticle Research20260 citations

   ABIABI:AkademIndex/openalex/2026.article.002183

4. Therapeutic targeting of cancer stem cell-specific surface glycans and glycoproteins

   Mutaz Jamal Al-khreisat, Waleed K. Abdulsahib, Ihsan Khudhair Jasim +6

   ArticleGlycosylation and Glycoproteins ResearchDiscover Oncology20260 citations

   ABIABI:AkademIndex/openalex/2026.article.003592

5. CAR‐NK Cell Biology and Engineering for Solid Tumors, With a Focus on Lung Cancer

   Xiao Lyu, Na Zhu, Ruijuan Guo +1

   ArticleCAR-T cell therapy researchCell Biology International20260 citations

   ABIABI:AkademIndex/openalex/2026.article.012258

6. The microbial metabolome: remodeling the therapeutic landscape in hematologic malignancies

   Liang Zhang, Hamed Soleimani Samarkhazan, Yaseer almajidi +1

   ArticleGut microbiota and healthnpj Biofilms and Microbiomes20260 citations

   ABIABI:AkademIndex/openalex/2026.article.013223

7. Advances in monitoring and therapy from minimal residual disease to CAR-T cells in multiple myeloma and precursor disorders

   Amr Ali Mohamed Abdelgawwad El‐Sehrawy, Ghaleb Oriquat, Sokhib Saidov +5

   ArticleCAR-T cell therapy researchClinica Chimica Acta20260 citations

   ABIABI:AkademIndex/openalex/2026.article.017391